Crystal Adam Insider Trades & Stock Holdings

President, R&D · Tango Therapeutics, Inc. · Latest filing Oct 1, 2026

Crystal Adam, President, R&D at Tango Therapeutics, Inc. has 1 Form 4 trade on file since Oct 1, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($660.80K), net -$660.80K. Latest filing: disposed of 27K shares of $TNGX on Oct 1, 2026 at $24.47.

Trades on file

1

Open-market bought

$0

Open-market sold

$660.80K

Net open-market

-$660.80K

Latest filing

Oct 1, 2026

All insider trades by Crystal Adam

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 1, 2026	$TNGX	Sell (Open-market sale) 10b5-1	27K	$24.47	$660.80K			-7.7%			President, R&D		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Crystal Adam traded

• $TNGX

Frequently asked questions

Has Crystal Adam been buying or selling stock?

Crystal Adam has 0 open-market purchases and 1 open-market sale on file, net -$660.80K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Crystal Adam's latest insider trade?

disposed of 27K shares of $TNGX on Oct 1, 2026 at $24.47.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.